Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)
Launched by SUN YAT-SEN UNIVERSITY · Apr 11, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The TRAIL Study is a research trial aimed at understanding tricuspid regurgitation, a condition where the heart's tricuspid valve doesn't close properly, leading to blood leaking backward into the heart. This study is looking at patients who have been diagnosed with this condition while they were in the hospital. Researchers want to learn more about the risk factors that can affect the health of these patients, particularly focusing on overall survival and heart-related events.
To be eligible for this study, you need to be at least 18 years old and have been diagnosed with tricuspid regurgitation during your hospital stay. Unfortunately, if you are unable to provide informed consent, you won't be able to participate. If you join the study, you can expect to be followed for a time to gather important information about your health and how this condition affects you. The study is currently recruiting participants, so if you or someone you know fits the criteria, this could be a valuable opportunity to contribute to important heart health research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged over 18 yrs.
- • Patients diagnosed with tricuspid regurgitation during hospitalization.
- Exclusion Criteria:
- • Patients unable to provide informed consent.
About Sun Yat Sen University
Sun Yat-sen University, a prestigious institution located in Guangzhou, China, is dedicated to advancing medical research and healthcare innovations. As a leading clinical trial sponsor, the university leverages its extensive academic resources and collaboration with top-tier medical professionals to conduct rigorous clinical studies. Committed to improving patient outcomes and contributing to global health knowledge, Sun Yat-sen University focuses on a wide range of therapeutic areas, employing cutting-edge methodologies to ensure the integrity and efficacy of its research initiatives. Through its clinical trials, the university aims to foster scientific advancements and enhance the quality of care provided to patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zhongshan, Guangdong, China
Zhanjiang, Guangdong, China
Jieyang, Guangdong, China
Shantou, Guangdong, China
Shenzhen, Guangdong, China
Guangzhou, Guangdong, China
Guangzhou, Guangdong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported